Comparison of the Leuven Protocol With the Glucommander for Postoperative Control of Blood Glucose With IV Insulin

Sponsor
Rush University Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT00795015
Collaborator
(none)
93
1
2
8
11.6

Study Details

Study Description

Brief Summary

The investigators are testing whether a written protocol or a computerized program can more effectively control blood glucose after surgery.

Condition or Disease Intervention/Treatment Phase
  • Drug: insulin regular IV infusion
  • Drug: IV insulin infusion
Phase 4

Detailed Description

In 2002 we adapted the protocol described by Van den Berghe et al. for use in our own surgical intensive care unit (SICU) with a target blood glucose range from 80 to 120mg/dL. After five years of implementation, we were able to achieve a mean BG of 117 mg/dL in the SICU. 2% of glucose values were <60 mg/dL in the SICU. Given the concern of safety while optimizing glycemic control, we investigated the etiologies for these hypoglycemic episodes and have found two frequent risk factors; the failure to consistently measure blood glucose every hour and in patients with end stage renal failure.

We will investigate whether a computer-based algorithm for the titration of IV insulin will translate to better clinical outcomes and less hypoglycemia. Therefore, we will conduct a prospective randomized trial comparing the Glucommander, a computer-based algorithm with our Van den Berghe protocol for titration of IV insulin in patients after cardiovascular or transplant surgery. This computer based algorithm was invented in 1984 in Atlanta by Dr. Davidson and Dr. Steed who have used it in a variety of applications of IV insulin.

Study Design

Study Type:
Interventional
Actual Enrollment :
93 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Comparison of the Leuven Protocol With the Glucommander for Postoperative Control of Blood Glucose With an Intravenous Insulin Infusion
Study Start Date :
Apr 1, 2006
Actual Primary Completion Date :
Dec 1, 2006
Actual Study Completion Date :
Dec 1, 2006

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: leuven

these patients had their IV insulin controlled by using the protocol adapted from van den Berghe et al. University of Leuven, Belgium, NEJM Nov. 2001

Drug: insulin regular IV infusion
IV insulin was administered by continuous infusion and the rate changed every hour according to the blood glucose level as determined by each of the protocols being compared

Drug: IV insulin infusion
IV insulin was administered by continuous infusion and the rate changed every hour according to the blood glucose level as determined by each of the protocols being compared

Active Comparator: glucommander

these subjects had IV insulin controlled by a computer program called the glucommander described by Davidson, P et al Diabetes Care Oct. 2005

Drug: insulin regular IV infusion
IV insulin was administered by continuous infusion and the rate changed every hour according to the blood glucose level as determined by each of the protocols being compared

Drug: IV insulin infusion
IV insulin was administered by continuous infusion and the rate changed every hour according to the blood glucose level as determined by each of the protocols being compared

Outcome Measures

Primary Outcome Measures

  1. Percent of blood glucose values in the target range 80-120 mg/dl [first 200 hours post-op in the ICU]

Secondary Outcome Measures

  1. Percent of patient days with a low blood glucose, defines as less than 60 mg/dl [200 hours while in ICU]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • s/p open heart or kidney or liver transplant surgery
Exclusion Criteria:
  • admission blood glucose less than 120 mg/dl

Contacts and Locations

Locations

Site City State Country Postal Code
1 Rush University Medical Center Chicago Illinois United States 60612

Sponsors and Collaborators

  • Rush University Medical Center

Investigators

  • Principal Investigator: David Baldwin, MD, Rush University Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00795015
Other Study ID Numbers:
  • 06010501
First Posted:
Nov 21, 2008
Last Update Posted:
Mar 16, 2011
Last Verified:
Mar 1, 2011
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 16, 2011